Sever loss of vision during adjuvant interferon alfa-2b treatment for malignant melanoma

Sever loss of vision during adjuvant interferon alfa-2b treatment for malignant melanoma

Lohmann et al discuss the case of a 60-year-old man with cutaneous melanoma, which was excised and subsequently treated with interferon alfa-2b. The patient experienced retinal and optic nerve complications with the therapy.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Lancet (British edition) 1999-04, Vol.353 (9161), p.1326
Hauptverfasser: Lohmann, Chris P, Kroher, Gisela, Bogenrieder, Thomas, Spiegel, Detlev, Preuner, Jurgen
Format: Artikel
Sprache:eng
Schlagworte:
Cancer
Case studies
Drug therapy
Eyes & eyesight
Melanoma
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Lohmann et al discuss the case of a 60-year-old man with cutaneous melanoma, which was excised and subsequently treated with interferon alfa-2b. The patient experienced retinal and optic nerve complications with the therapy.
ISSN:0140-6736
1474-547X